Form 8-K - Current report:
SEC Accession No. 0000950170-24-082994
Filing Date
2024-07-11
Accepted
2024-07-11 16:53:18
Documents
11
Period of Report
2024-07-10
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K acor-20240710.htm   iXBRL 8-K 47625
  Complete submission text file 0000950170-24-082994.txt   162971

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT acor-20240710.xsd EX-101.SCH 24851
14 EXTRACTED XBRL INSTANCE DOCUMENT acor-20240710_htm.xml XML 4712
Mailing Address TWO BLUE HILL PLAZA PEARL RIVER NY 10965
Business Address TWO BLUE HILL PLAZA PEARL RIVER NY 10965 914-347-4300
Acorda Therapeutics, Inc. (Filer) CIK: 0001008848 (see all company filings)

EIN.: 133831168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31938 | Film No.: 241112533
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)